The 85 kDa cytosolic phospholipase A 2 (cPLA 2 ) plays a key role in liberating arachidonic acid from the sn-2 position of membrane phospholipids. When activated by extracellular stimuli, cPLA 2 undergoes calciumdependent translocation from cytosol to membrane sites which are still a matter of debate. In order to evaluate the effect of plasma membrane association on cPLA 2 activation, we constructed chimeras of cPLA 2 constitutively targeted to the plasma membrane by the N-terminal targeting sequence of the protein tyrosine kinase Lck (Lck-cPLA 2 ) or the C-terminal targeting signal of K-Ras4B (cPLA 2 -Ras). Constitutive expression of these chimeras in Chinese hamster ovary cells overproducing the a 2B adrenergic receptor (CHO-2B cells) did not affect the basal release of [ 3 H]arachidonic acid, indicating that constitutive association of cPLA 2 with cellular membranes did not ensure the hydrolysis of membrane phospholipids. However, Lck-cPLA 2 increased [ 3 H]arachidonic acid release in response to receptor stimulation and to increased intracellular calcium, whereas cPLA 2 -Ras inhibited it, compared with parental CHO-2B cells and CHO-2B cells producing comparable amounts of recombinant wild-type cPLA 2 . The lack of stimulation of cPLA 2 -Ras was not due to a decreased enzymatic activity as measured using an exogenous substrate, or to a decreased phosphorylation of the protein. These results show that the plasma membrane is a suitable site for cPLA2 activation when orientated correctly.
Phospholipases A 2 (PLA 2 ) belong to a growing superfamily of enzymes which hydrolyze membrane phospholipids into fatty acids and lysophospholipids, providing the precursors for many of the lipid mediators involved in regulating physiological and pathological processes [1] . There are at least three groups of PLA 2 s in mammalian cells: Ca 2+ -dependent secretory PLA 2 s (sPLA 2 s), intracellular Ca 2+ -independent PLA 2 s (iPLA 2 s) and the cytosolic 85-kDa Ca 2+ -dependent PLA 2 (cPLA 2 ). Recent evidence indicates that cPLA 2 plays a major role in the overproduction of lipid mediators during inflammation [2, 3] . cPLA 2 activated by extracellular stimuli triggers the rapid hydrolysis of membrane phospholipids to give free arachidonic acid (D 4 Ach), which is the rate-limiting step of eicosanoid production [4, 5] . This activation is dependent on at least two mechanisms: the phosphorylation of cPLA 2 by various kinases and its translocation to membrane phospholipids by a Ca 2+ -dependent lipid-binding domain (CaLB domain) [6] , following an increase in intracellular Ca 2+. This gives this cytosolic enzyme access to its membrane substrate [7, 8] . However, the way in which cPLA 2 is activated by extracellular stimuli, and whether this activation occurs at specific sites are not yet known. Various intracellular sites of translocation have been found for cPLA 2 , depending on the cell type and the stimulus used. They include nuclear and endoplasmic reticulum membranes [9±13], where cPLA 2 could colocalize with the enzymes transforming D 4 Ach into eicosanoids, the cyclooxygenases and lipoxygenases [12, 14] . However, little is known about the relative importance of these different sites for cPLA 2 activation. The plasma membrane may also be a possible site for translocation of cPLA 2 , but early studies suggesting the direct interaction of PLA 2 with heterotrimeric G proteins have not been confirmed [15] . Recent data indicating that cPLA 2 interacts with Jak kinases [16] or is activated by phosphatidylinositol 4,5-bisphosphate [17] have raised the possibility that translocation of cPLA 2 to the plasma membrane might be part of its activation by membrane receptors. Such a translocation of cPLA 2 to the plasma membrane was recently observed in confluent endothelial cells [18] .
In order to evaluate the influence of plasma membrane anchoring on cPLA 2 activation, we have constructed chimeras of cPLA 2 by adding C-terminal or N-terminal plasma membrane targeting signals to the molecule. We added the plasma membrane targeting signal of the Lck protein kinase to the N-terminus of the cPLA 2 [19] and the plasma membrane localizing sequence of K-Ras4B to the C-terminus [20] . These chimeras were expressed in Chinese hamster ovary (CHO) cells overproducing the G-protein-coupled a 2B adrenergic receptor (CHO-2B cells). CHO cells contain three forms of PLA 2 s, like many other cell types, and they seem to play different roles in D 4 Ach release: an sPLA 2 , which is not involved in rapid receptor-mediated D 4 Ach release [4, 21] , an iPLA 2 [22] , which q FEBS 1999 is mainly involved in the remodeling of membrane phospholipids [23] , and cPLA 2 , which is responsible for D 4 Ach release after stimulation by extracellular agonists or an increase in intracellular Ca 2+ [4, 5] . In CHO-2B cells it was possible to separately induce receptor-mediated phosphorylation and activation of cPLA 2 by Ca 2 [24] . Stimulation of the receptor with epinephrine causes pertussis toxin-sensitive, Ras-independent activation of mitogen-activated protein kinase (MAP kinase; [25] ), leading to cPLA 2 phosphorylation [24, 26] , but has only a modest effect on the release of D 4 Ach [24] . Free D 4 Ach is maximally produced by stimulating the cells with both epinephrine and the Ca 2+ ionophore A23187, which results in a massive entry of extracellular Ca 2+ [24] . We used this cell model to determine whether targeting cPLA 2 to the plasma membrane led to the constitutive hydrolysis of membrane phospholipids or could promote an increase in cPLA 2 activation in response to receptor stimulation, increased intracellular Ca 2+ , or both. Our results show that the N-terminal and C-terminal lipid-modified anchoring sequences used promote a constitutive targeting of cPLA 2 to the plasma membrane. In contrast with wild-type cPLA 2 , the two chimeras have a significant but opposite effect on D 4 Ach release by receptor stimulation or by Ca 2 . These results suggest a new mechanism involving plasma membrane components in the regulation of cPLA 2 activation.
E X P E R I M E N T A L P R O C E D U R E S

Plasmids and recombinant viruses construction
The cPLA 2 cDNA was obtained from the wild-type cPLA 2 / PVL1393 plasmid [27] by PCR. A Kozak consensus sequence was added to the forward primer and a NheI site was placed just before the stop codon in the reverse primer. The digested PCR product was inserted into the KpnI and BglII sites of the pcDNA3 to obtain the wild-type cPLA 2 /pcDNA3. Three successive PCR were performed to epitope-tag cPLA 2 at the N-terminus. A Kozak consensus sequence and the epitope tag sequence of human c-Myc (MEQKLISEEDL) were introduced at the N-terminus of wild-type cPLA 2 through three successive rounds of PCR by using three overlapping forward primers and a common reverse primer encompassing the unique EcoRI site of cPLA 2 cDNA. The digested PCR product was then ligated into the KpnI and EcoRI sites of the wild-type cPLA 2 /pcDNA3 to obtain the myc-cPLA 2 /pcDNA3. A similar procedure was used to fuse the N-terminal 10 amino acids of human Lck (MGCGCSSHPE) to the N-terminal end of cPLA 2 . The PCR product was ligated into the wild-type cPLA 2 /pcDNA3 to obtain the Lck-cPLA 2 /pcDNA3. To obtain the sequence encoding the 18 C-terminal amino acids of mouse K-Ras4B (SKDGKKKKKKSRTRCTVM), a sense oligonucleotide containing a NheI site and the coding sequence of the first 15 amino acids of the K-Ras4B C-terminus was hybridized to an antisense oligonucleotide encoding the last 12 amino acids of K-Ras4B, a stop codon and a XhoI site. The double-stranded DNA fragment was blunt-ended by Vent Polymerase, digested and ligated into the NheI and XhoI sites of the wild-type cPLA 2 expression plasmid to obtain the cPLA 2 -Ras/pcDNA3. The Lck-cPLA 2 and cPLA 2 -Ras cDNA were amplified by using the respective pcDNA3 constructs as template and inserted into the PVL 1393 plasmid. The corresponding PVL 1393 constructs and the linear transfection module from Pharmingen were used to obtain recombinant viruses from Spodoptera frugiperda (Sf 9) cells cultures. All constructs were verified by DNA sequencing.
Cell culture, stable transfection of CHO-2B cells, infection of Sf 9 cells
The CHO cells stably expressing the rat a 2B adrenergic receptor (CHO-2B cells) were maintained as described previously [25] . CHO-2B cells were stably transfected with either wild-type cPLA 2 /pcDNA3, myc-cPLA 2 /pcDNA3, Lck-cPLA 2 /pcDNA3 or cPLA 2 -Ras/pcDNA3 using the calcium phosphate precipitation method. Resistant clones were selected in medium supplemented with 0.8 mg´mL 21 G418 and picked out by trypsinization using cloning rings. Individual clones were screened by immunoblot analysis. Stably transfected cells were maintained in complete medium supplemented with 0.65 mg´mL 21 G418. All cells were maintained for up to 10 passages after thawing at 37 8C in a 5% CO 2 incubator.
Sf 9 insect cells were grown at 27 8C in Grace's medium supplemented with 100 U´mL 21 penicillin, 100 mg´mL 21 streptomycin, 10% fetal bovine serum. Sf 9 cells were allowed to adhere to tissue culture dishes for 1 h and then were infected at a multiplicity of infection of 10±20 for 1 h with the appropriate recombinant virus (wild-type cPLA 2 , Lck-cPLA 2 or cPLA 2 -Ras recombinant baculovirus). All the experiments were performed at 68±70 h postinfection.
Transient transfection and immunofluorescence analysis
CHO-2B cells were plated on glass coverslips at 3 Â 10 5 cells per well in six-well plates and grown for 18 h. Cells were transfected with 0.5 mg of each indicated plasmid using Lipofectamine-PLUS reagent (Life Technologies). Immunostaining experiments were all performed 48 h after the start of transfection, at room temperature. Transiently transfected cells were washed three times with NaCl/P i , (140 mm NaCl, 10 mm P i ) fixed with 2% paraformaldehyde in NaCl/P i for 10 min, washed three times with NaCl/P i , incubated for 10 min with 50 mm NH 4 Cl, again washed three times in NaCl/P i and then permeabilized with 0.075% saponin in NaCl/P i for 10 min. Cells were washed three times and incubated for 1 h with primary anti-cPLA 2 4 Ach was removed, confluent cells were washed with NaCl/P i containing 0.2% fatty acid-free BSA, and incubated for 15 min in fresh medium alone (unstimulated cells) or in medium containing 1 mm epinephrine, 1 mm calcium ionophore A23187, or both. The medium was removed and centrifuged at 2000 g to remove cell debris. The cells were washed and scraped off. The radioactivity in the cells and media was measured by scintillation counting. The release of 
Phospholipase A 2 activity
Cell lysates from Sf 9 cells producing wild-type cPLA 2 , cPLA 2 -Ras or Lck-cPLA 2 were isolated as described above. The phospholipase A 2 activity was determined using 4 mm of [27] . The assay mixture contained 100 mm Tris/HCl pH 8.5, 30% glycerol, 50 mm Triton X-100, 5 mm CaCl 2 , 0.1% (w/v) fatty acid-free BSA and 300 ng of cell lysates, in a final volume of 250 mL. The mixture was incubated at 37 8C for 10 min and the lipids were extracted using the Bligh and Dyer procedure [27] . After separation by TLC, radioactivity of free fatty acid and phosphatidylcholine was quantified by liquid scintillation counting. The percentage of hydrolysis of the substrate was used to calculate the specific activity of the enzyme in the cell lysates.
Immunoprecipitation
Immunoprecipitation of cPLA 2 -Ras from cPLA 2 -Ras CHO cells using an anti-KRas4B and of [ 32 P]-labeled wild-type cPLA 2 or cPLA 2 -Ras from infected Sf 9 cells using an anticPLA 2 antibody was performed as follows. Infected Sf 9 cells (68 h postinfection) or confluent CHO cells were washed three times with ice-cold NaCl/P i containing 1 mm sodium orthovanadate and lysed in 1 mL ice-cold lysis buffer (10 antipain, 1 mg´mL 21 aprotinin). After sonication (Ultrasonic Cleaner Branson-1200 for 1 min), lysates were clarified by centrifugation at 15 000 g for 15 min at 4 8C and precleared by incubation with 50 mL mouse or rabbit IgG±agarose beads (Jackson ImmunoResearch Laboratories) for 1 h at 4 8C. The resulting supernatants were transferred to a microfuge tube containing 1.5 mg mouse monoclonal anti-cPLA 2 (Santa-Cruz, sc-454), or 1 mg rabbit polyclonal anti-KRas4B (Santa-Cruz, sc-521) and mixed by gentle rotation overnight at 4 8C. Protein A/G PLUS±agarose beads (Santa Cruz) were added for 2 h at 4 8C. The immunoprecipitates were recovered by centrifugation, washed five times with 1 mL ice-cold lysis buffer, boiled for 5 min in 1Â Laemmli buffer containing 0. 5 
R E S U L T S
Targeting of cPLA 2 to the plasma membrane by Lck and Ras sequences cPLA 2 was targeted to the plasma membrane by the addition of lipid-modified anchoring sequences. The 10 first amino acidtargeting signal of the Lck protein kinase in which Gly2 is myristoylated and Cys3 and Cys5 are palmitoylated was added at the N-terminus of the cPLA 2 (Fig. 1, Lck-cPLA 2 ). This dual acylation motif has been used previously to target cytosolic proteins to the plasma membrane [19] . The C-terminal 18 amino acids of K-Ras4B containing a polybasic domain of six lysine residues and ended by a CAAX box (CTVM) was added to the C-terminus of cPLA 2 . This CAAX box undergoes postranslational modifications, including farnesylation of the cysteine, proteolysis and carboxymethylation (Fig. 1, cPLA 2 Ras). This sequence ensures the plasma membrane localization of K-Ras4B [31] , and has been used to anchor cytosolic proteins to the plasma membrane [20, 32] . Plasmids containing cDNAs encoding human wild-type cPLA 2 (Fig. 1, WT cPLA 2 ) or c-myc epitope-tagged cPLA 2 (Fig. 1 , myc-cPLA 2 ) were used as controls to compare the effects of cytosolic overproduction of cPLA 2 with that of targeting cPLA 2 to membranes.
Indirect immunofluorescence microscopy was used to determine the location of endogenous cPLA 2 in parental CHO-2B 4 Ach from prelabeled cells [24] . However, stimulation with these agonists produced no detectable translocation of endogenous cPLA 2 from cytosol to membranes in agreement with a recent report [33] .
The CHO-2B cells were transiently transfected with either wild-type cPLA 2 , myc-cPLA 2 , Lck-cPLA 2 or cPLA 2 -Ras expression plasmids. Wild-type cPLA 2 and myc-cPLA 2 had a similar pattern of distribution within the cytoplasm (Fig. 2B , C, respectively), but with more intense staining than endogenous cPLA 2 ( Fig. 2A) , suggesting that the very weak signal in parental cells was not due to a loss of soluble cPLA 2 during the staining procedure. By contrast, Lck-cPLA 2 and cPLA 2 -Ras which contained an N-terminal or C-terminal plasma membrane targeting sequence showed a distribution very different to wild-type cPLA 2 with distinct staining in the plasma membrane (Fig. 2D,E, respectively) . A vesicular structure adjacent to the nucleus was also stained in cells producing Lck-cPLA 2 (Fig. 2D) . No signal was detected within the nucleus or the nuclear membrane. These results clearly demonstrated that addition of an N-terminal or C-terminal plasma membrane targeting sequence to cPLA 2 promoted plasma membrane association.
Anchoring of cPLA 2 to the plasma membrane has no effect on the basal release of [ The effect of the constitutive location of cPLA 2 at the plasma membrane on its activation was examined using CHO cell lines stably producing either Lck-cPLA 2 , cPLA 2 -Ras, myc-cPLA 2 or wild-type cPLA 2 . The cells were generated by stably transfecting CHO cells overproducing rat a 2B adrenergic receptor (CHO-2B cells). Immunofluorescence showed the same pattern of distribution as that of transiently transfected cells, although the staining was less intense (not shown). Cytosol and crude membranes of each cell line were separated and analysed by anti-cPLA 2 immunoblotting. Lck-cPLA 2 , cPLA 2 -Ras and myc-cPLA 2 all had reduced electrophoretic mobility, probably due to the addition of 9±18 amino acids, but wild-type cPLA 2 did not (Fig. 3) . Parental CHO-2B cells contained endogenous cPLA 2 mainly in the cytosol, with a small amount in membranes (Fig. 3, CHO-2B ). There was increased wild-type cPLA 2 Fig. 2 . Subcellular distribution of wild-type cPLA 2 , myc-cPLA 2 , Lck-cPLA 2 and cPLA 2 -Ras in CHO-2B cells. Parental CHO-2B cells (A) and cells transiently transfected with either wild-type cPLA 2 (B), myc-cPLA 2 (C), Lck-cPLA 2 (D) or cPLA 2 -Ras (E) constructs were stained with a polyclonal anti-cPLA 2 and a FITC-conjugated second antibody (green). Nuclei were stained with propidium iodide (red). Immunofluorescent staining was visualized by confocal microscopy. Note the plasma membrane distribution of Lck-cPLA 2 (D) and cPLA 2 -Ras (E) as opposed to the punctate cytoplasmic distribution of wild-type cPLA 2 (B) and myc-cPLA 2 (C). Immunofluorescence analysis was also performed on stable transfectants producing the various forms of cPLA 2 . The patterns of staining were similar to those of the transiently transfected cells. Bar, 10 mm. Fig. 1 . Schematic representation of the wild-type cPLA 2 , myccPLA 2 , LckcPLA 2 and cPLA 2 Ras constructs. Wild-type cPLA 2 (WT cPLA 2 ) was epitope-tagged at its N-terminus with the c-myc epitope tag (myc-cPLA 2 ). cPLA 2 was targeted to the plasma membrane by adding N-terminal or C-terminal plasma membrane targeting signal to wild-type cPLA 2 . The 10 first amino acids of the Lck protein kinase were added to its N-terminus (Lck-cPLA 2 ). This motif is myristoylated on Gly2 (G), and palmitoylated on Cys3 and 5 (C). The 18 last amino acids of K-Ras4B were added to its C-terminus (cPLA 2 -Ras). This motif undergoes post-translational modifications, including farnesylation of the cysteine (C). Fig. 3 . Distribution of wild-type cPLA 2 , myc-cPLA 2 , Lck-cPLA 2 and cPLA 2 -Ras in the cytosolic and membrane fractions of CHO cells. Cytosolic fractions (25 mg) and crude membrane fractions (100 mg) of parental CHO-2B cells and stable transfectants producing wild-type cPLA 2 , myc-cPLA 2 , Lck-cPLA 2 or cPLA 2 -Ras were resolved by 7.5% SDS/PAGE (overnight) and detected with a monoclonal anti-cPLA 2 . Under these conditions, myc-cPLA 2 , Lck-cPLA 2 and cPLA 2 -Ras have reduced electrophoretic mobility compared with endogenous cPLA 2 and wild-type cPLA 2 .
and myc-cPLA 2 in the cytosolic fraction of the corresponding stable transfectants (Fig. 3 , WT cPLA 2 CHO and myc-cPLA 2 CHO), giving between three and five times the amount of endogenous cPLA 2 in cell lysates (Fig. 4A) , and to a lesser extent there was increased myc-cPLA 2 in membranes. In contrast, there was increased Lck-cPLA 2 and cPLA 2 -Ras in the membrane fraction but not in the cytosol of the corresponding stable transfectants (Fig. 3 , Lck-cPLA 2 CHO and cPLA 2 -Ras CHO), giving 2.5 and 2 times the amount of endogenous cPLA 2 in cell lysates (Fig. 4A) .
We then tested the ability of chimeric Lck-cPLA 2 and cPLA 2 -Ras to modify the release of [ (Table 1 ). This result was expected for wild-type cPLA 2 and myc-cPLA 2 , which are overproduced in the cytosol where they do not have access to their phospholipid substrate. The lack of increase of basal D 4 Ach release in Lck-cPLA 2 and cPLA 2 -Ras CHO cells was more surprising, showing that constitutive association of cPLA 2 with membranes by means other than the CaLB domain does not ensure the hydrolysis of membrane phospholipids in unstimulated cells.
We have previously shown that stimulation of the a 2B adrenergic receptor in CHO-2B cells with epinephrine produces a small but significant increase in D 4 Ach release [24] . The maximal stimulation of D 4 Ach release was obtained by stimulating the cells with 1 mm epinephrine plus the calcium ionophore A23187, which potentiates the stimulation induced Fig. 4. N-terminal 2 CHO cells in response to epinephrine, calcium ionophore A23187, or both, showing that N-terminal anchoring of cPLA 2 to the plasma membrane had a positive effect on its stimulation (Fig. 4C, hatched bars) , but was still sensitive to calcium. However, cPLA 2 -Ras decreased the release of D 4 Ach induced by the same agonists twofold compared with parental cells (Fig. 4C, solid bars) . This effect of cPLA 2 -Ras suggests that the C-terminal anchoring of cPLA 2 not only inhibits its activation, but also interferes with the activation of endogenous cPLA 2 .
The membrane-bound cPLA 2 -Ras is enzymatically active, is phosphorylated but is weakly activated in response to stimuli
The first explanation for the lack of activation of cPLA 2 -Ras was that C-terminal anchoring decreased or abolished the enzymatic activity of the protein. To verify this hypothesis, we first measured the cPLA 2 enzymatic activity in membranes isolated from parental CHO-2B cells and cPLA 2 -Ras CHO cells using an exogenous radiolabeled substrate [27] . The very low activity in both cell lines prevented evaluation of any significant difference between endogenous cPLA 2 and cPLA 2 -Ras (not shown). We then used a more sensitive assay to measure the ability of cPLA 2 -Ras to hydrolyze membrane phospholipids in vitro. Crude membranes were incubated with calcium. The release of free fatty acids was quantified by GC coupled to MS [34] , showing that cPLA 2 -Ras released fatty acids as efficiently as endogenous cPLA 2 (not shown). In order to compare more accurately the activity of cPLA 2 -Ras with that of wild-type cPLA 2 , we used the baculovirus±Sf 9 insect cell system which produces high levels of recombinant proteins. Moreover, uninfected Sf 9 cells can be considered to be free of cPLA 2 as they contain no immunoreactive cPLA 2 and have no cytosolic PLA 2 activity when measured using an exogenous radiolabeled arachidonyl-phosphatidylcholine (not shown). Figure 5 shows that wild-type cPLA 2 and cPLA 2 -Ras as well as Lck-cPLA 2 , produced at the same level in Sf 9 cells (Fig. 5B) , exhibit similar specific activities (Fig. 5A) .
Next we examined the possibility that the lack of cPLA 2 -Ras activation was because of a lack of phosphorylation in response to agonists. Several studies have shown that agonist-induced phosphorylation of cPLA 2 on Ser505 reduces its electrophoretic mobility on SDS/PAGE [26] . Incubation of CHO-2B cells with epinephrine induced a gel shift of endogenous cPLA 2 in membrane fractions (Fig. 6A, CHO-2B ). The same gel retardation was observed in membrane fractions of cPLA 2 -Ras CHO cells for both endogenous cPLA 2 and cPLA 2 -Ras (Fig. 6A , cPLA 2 -Ras CHO). The mobility shift of cPLA 2 -Ras was confirmed by immunoprecipitation of the chimera using an anti-KRas4B (Fig. 6B) . In addition, expression of cPLA 2 -Ras did not seem to prevent the phosphorylation of endogenous cPLA 2 as epinephrine caused a mobility shift of endogenous cPLA 2 in the cytosol of both CHO-2B and cPLA 2 -Ras CHO cells (Fig. 6C) . We then compared the phosphorylation level of cPLA 2 -Ras and wild-type cPLA 2 by producing the recombinant proteins in Sf 9 cells which perform the same post-translational modifications of recombinant proteins as do mammalian cells, including phosphorylation of human recombinant wild-type cPLA 2 [30] . The phosphorylation of wild-type cPLA 2 and cPLA 2 -Ras was examined using Sf 9 cells metabolically labeled with [ 32 P]phosphate for 48 h. The amounts of [ 32 P] incorporated into wild-type cPLA 2 and cPLA 2 -Ras were identical in unstimulated cells (Fig. 7A) producing the same amounts of recombinant cPLA 2 s (Fig. 7B) . Stimulation of the cells with the phosphatase inhibitor okadaic acid caused similar increases in [ 32 P] incorporation into both wild-type cPLA 2 and cPLA 2 -Ras (Fig. 7A) .
We therefore used this cell system to evaluate the contributions of wild-type cPLA 2 2 or cPLA 2 -Ras (not shown). In agreement with a previous study [30] , the production of wild-type cPLA 2 
D I S C U S S I O N
We have used CHO cells overproducing the rat a 2B adrenergic receptor (CHO-2B cells) as cells that discriminate between receptor-specific phosphorylation and activation of cPLA 2 by calcium. These two key events leading to the activation of cPLA 2 can be induced separately in these cells, phosphorylation by epinephrine and activation by calcium ionophore [24] . Endogenous cPLA 2 is poorly expressed in CHO-2B cells and is found mainly in the cytosol, as shown by indirect immunofluorescence microscopy and by immunoblotting of cytosolic and membrane fractions. Using these techniques we detected no translocation to membranes in response to epinephrine, calcium ionophore or both. This contrasts with the findings of other studies, in which increasing intracellular calcium or stimulating G-protein-coupled receptors caused the translocation of cPLA 2 to the endoplasmic reticulum [10] , to the nuclear membrane [9, 10, 13] or to the plasma membrane [18] . But this agrees with other recent results that found no detectable translocation in EGF/A23187-stimulated Her 14 fibroblasts [33] . However, in studies where cPLA 2 was shown to translocate to a definite membrane, it is possible that small amounts of cPLA 2 were translocated to other membrane sites but were not detected. In addition, even when cPLA 2 has been demonstrated to translocate to a definite cell compartment, there is still no clear evidence that cPLA 2 is activated at these sites.
The present study uses another approach to evaluate a possible regulatory role of plasma membrane association on cPLA 2 activation. We constructed chimeras of cPLA 2 , which were constitutively targeted to the plasma membrane by N-terminal or C-terminal lipid-modified anchoring sequences (Lck-cPLA 2 and cPLA 2 -Ras), whereas wild-type cPLA 2 and epitope-tagged cPLA 2 (myc-cPLA 2 ) remained in the cytosol. Four cell lines overproducing these recombinant cPLA 2 s to the same extent were established to evaluate the influence of plasma membrane targeting on cPLA 2 activation. The release of [ 3 H]D 4 Ach from prelabeled cells was used to assay cPLA 2 activation in whole cells. The basal release of D 4 Ach was unaffected by the overproduction of cPLA 2 in cytosol (wild-type cPLA 2 and myc-cPLA 2 ). This is in agreement with previous results showing that iPLA 2 is involved in the basal release of D 4 Ach, while cPLA 2 is not [23] . More surprisingly, the basal release of D 4 Ach was also unchanged by the constitutive presence of Lck-cPLA 2 and cPLA 2 -Ras at the plasma membrane (Table 1 ). This shows that constitutive association of cPLA 2 with membranes is not sufficient to cause the hydrolysis of membrane phospholipids.
In contrast, the N-terminal anchoring of cPLA 2 enhanced its ability to be activated by stimuli. The constitutive production of Lck-cPLA 2 increased the release of [ 3 H]D 4 Ach stimulated by epinephrine threefold (Fig. 4C), showing its responsiveness to G-protein-coupled receptor transduction pathway. Surprisingly, Fig. 8 . A putative caveolin-binding motif, located at the C-terminal end of cPLA 2 (residues 683±690) is conserved from human to zebrafish and is identical to the caveolin binding motif of PKCa, a known caveolininteracting protein. F represents aromatic residues and X denotes any amino acid.
q FEBS 1999 stimulation with calcium ionophore was also enhanced in Lck-cPLA 2 CHO cells over that of wild-type cPLA 2 CHO cells (Fig. 4C) , showing that N-terminal plasma membrane anchoring of cPLA 2 does not render it insensitive to calcium. This confirms that the CaLB domain of cPLA 2 is not only necessary for cPLA 2 translocation to membranes, but may also take part in activation by promoting specific interaction with phospholipids [35, 36] , thus allowing the orientation of the catalytic domain of the enzyme. cPLA 2 -Ras produced at the same level as Lck-cPLA 2 cells did not enhance the release of D 4 Ach induced by the agonists, and even inhibited it significantly (Fig. 4C ). This lack of activation was confirmed by the weak stimulation of D 4 Ach release by Sf 9 cells producing cPLA 2 -Ras, but devoid of endogenous cPLA 2 (Fig. 7C) . The three-dimensional structure of cPLA 2 has been elucidated recently [37] confirming that the amino acids of the active site lie within a large C-terminal domain of the enzyme [6, 38] . We could not rule out that the addition of a C-terminal sequence to cPLA2 might have disturbed the conformation of the enzyme resulting in decreased activity. But this did not seem to be the case, because cPLA 2 -Ras produced in Sf 9 cells exhibited a specific PLA 2 activity in the same range than that of wild-type cPLA 2 and Lck-cPLA 2 (Fig. 5A) .
We also examined the possibility that cPLA 2 -Ras was unphosphorylated in response to agonists and/or prevented the phosphorylation of endogenous cPLA 2 . Phosphorylation of cPLA 2 by various kinases, including MAP kinases, is presumed to occur in the cytosol and to be required for its translocation [39] and activation [26] . Hence, the membrane-bound cPLA 2 -Ras might not be accessible to phosphorylation by kinases. Our results show that both the recombinant cPLA 2 -Ras and the endogenous cPLA 2 were shifted in epinephrine-stimulated cPLA 2 -Ras CHO cells, showing that the membrane-bound cPLA 2 -Ras was phosphorylated and did not prevent the phosphorylation of endogenous cPLA 2 (Fig. 6 ). Moreover, the phosphorylation level of wild-type cPLA 2 and cPLA 2 -Ras was identical in unstimulated Sf 9 cells and was increased to the same extent by stimulating the cells with the phosphatase inhibitor okadaic acid (Fig. 7A) . Hence, the lack of activation of cPLA 2 -Ras is not due to either defective enzymatic activity or to a lack of phosphorylation, but perhaps to the inappropriate orientation of the active site towards membrane phospholipids in situ [37] .
Our results show that plasma membrane anchoring of cPLA 2 by a N-terminus or a C-terminus lipid-modified targeting sequence has a major influence on its activation. The anchoring might modify the configuration of the enzyme or its accessibility to the substrate, altering its ability to be activated in situ. However, this does not explain why Lck-cPLA 2 is activated more efficiently than wild-type cPLA 2 .
The two plasma membrane targeting sequences used to construct Lck-cPLA 2 and cPLA 2 -Ras belong to the Src family of protein tyrosine kinases and to the family of p21 Ras monomeric G proteins. These two classes of proteins associate with specialized domains of the plasma membrane, the caveolae, where a variety of signaling molecules are concentrated. Therefore, another hypothesis to explain our results is that the chimeras Lck-cPLA 2 and cPLA 2 -Ras could be targeted to the caveolae. The major structural component of caveolae is caveolin, a 21 to 24-kDa integral membrane protein. Caveolin 1 interacts directly with a variety of signaling molecules [Ha-Ras, Src family tyrosine kinases, G protein a subunits, endothelial NOS, epidermal growth factor (EGF) receptor and protein kinase C (PKC) isoforms]. This interaction is mediated by a scaffolding domain within caveolin, which recognizes a common sequence motif within caveolin-binding proteins (FXFXXXXF and FXXXXFXXF, where F is an aromatic amino acid and X denotes any amino acid; 40). We found a putative caveolin binding motif (FQYPNQAF) in the C-terminal end of the cPLA 2 sequence (residues 683±690; Fig. 8 ). This motif is present in all species examined to date, from human to zebrafish [6] , and is identical to the caveolin-binding motif of PKC-a, a known caveolin-interacting protein [40] .
Furthermore, preliminary results of co-immunoprecipitation show that Lck-cPLA 2 , but not cPLA2-Ras or endogenous cPLA2, interacts with caveolin 1 (unpublished results). This interaction might occur through the caveolin-binding motif of cPLA 2 as the 10 first amino acids of Lck do not contain any caveolin-binding motif. Therefore, it seems likely that the N-terminal targeting of Lck-cPLA 2 allows its interaction with caveolin 1, which might account for its enhanced activation. This hypothesis is consistent with the caveolar location of molecular components involved in the regulation of cPLA 2 activation. For example, the MAP kinases ERK-1/2 are concentrated in caveolae membranes [41] and caveolin regulates the p42/44 MAP kinase cascade [42] involved in the agonistinduced phosphorylation of cPLA 2 . The protein p11, a member of S100 family proteins, forms a heterotetrameric annexin II 2 p11 2 complex that is concentrated in caveolae [43] . This protein interacts with a large C-terminal domain of cPLA 2 , inhibiting its enzymatic activity [44] . Also, phosphatidylinositol 4,5-bisphosphate, which is concentrated in caveolae [45] , interacts with a putative pleckstrin homology domain of cPLA 2 , resulting in increased enzymatic activity [17] . Similarly, diacylglycerol, which is also concentrated in caveolae [46] promotes cPLA 2 activity [47] . Consistent with this hypothesis, preliminary experiments on an epithelial cell line show that endogenous cPLA2 is located at the plasma membrane in unstimulated cells and that cPLA2 cofractionates with caveolin 1 in detergent-resistant membranes (unpublished results).
Taken together, our results show that anchoring cPLA 2 to the plasma membrane has no effect on phospholipids hydrolysis in unstimulated cells, but modulates its activation. Moreover, the way cPLA 2 is anchored determines its ability to release arachidonic acid in response to stimuli. Finally, these results show that plasma membrane is a suitable site for cPLA 2 activation when correctly orientated. Moreover, interaction of cPLA 2 with plasma membrane microdomains such as caveolae should be explored further as a possible regulatory mechanism in cPLA 2 activation.
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